Exploring the Association between Blood Indices and Skin and Joint Activity of Psoriatic Arthritis

被引:0
|
作者
Rostamian, Abdolrahman [1 ]
Aghayani, Shila [2 ]
Najafizadeh, Seyed Reza [3 ]
Saffarian, Zahra [4 ]
Yaseri, Maryam [3 ]
机构
[1] Univ Tehran Med Sci, Dept Internal Med, Imam Khomeini Hosp Complex, Sch Med, Tehran, Iran
[2] Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Sch Med, Dept Rheumatol, Tehran, Iran
[3] Univ Tehran Med Sci, Vali E Asr Hosp, Rheumatol Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Sch Med, Dept Dermatol, Tehran, Iran
关键词
Hematologic test; Psoriatic arthritis; Psoriasis; DISEASE-ACTIVITY;
D O I
10.18502/ijaai.v23i6.17375
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The exact cause of psoriatic arthritis is still unknown, but hypotheses suggest the role of hematological parameters in the onset and severity of the disease. This study evaluated the hematological indices and their association with skin and joint activity in psoriatic arthritis. This cross-sectional study included 74 patients with psoriatic arthritis. Demographical and clinical data, blood indices, psoriasis area and severity index (PAST) score and disease activity in psoriatic arthritis (DAPSA) scores were calculated for all patients. The mean age of the patients was 48.89 +/- 12.03 years and most were female (n=49). A significant correlation was observed between age and number of underlying diseases with PAST and DAPSA scores. Mean PAST and DAPSA scores were 5.19 and 15.13, respectively. The severity of psoriasis was mild in 58.1%, moderate in 36.5%, and severe in 4.5% of the cases. The activity of psoriatic arthritis was improved in 2.1%, low in 55.4%, moderate in 24.3%, and high in 1.8% of the patients. A significant association was found between erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), platelet (PLT) count, mean platelet volume (MPV), and PAST scores, while no statistically significant association was reported for PLR. A significant correlation was observed between ESR, CRP, RDW, NLR, PLR, PLT, and DAPSA scores, while no statistically significant association was found for MPV. The findings indicated that inflammatory and hematological markers can be helpful factors in evaluating the severity of psoriasis and psoriatic arthritis.
引用
收藏
页码:651 / 661
页数:11
相关论文
共 50 条
  • [31] The Relationship Between Fatigue and Disease Activity as Determined by Different Indices in Patients with Psoriatic Arthritis (PsA)
    Duruoz, Mehmet Tuncay
    Gezer, Halise Hande
    Nas, Kemal
    Kilic, Erkan
    Sargin, Betul
    Kasman, Sevtap Acer
    Alkan, Hakan
    Sahin, Nilay
    Cengiz, Gizem
    Cuzdan, Nihan
    Gezer, Ilknur Albayrak
    Keskin, Dilek
    Mulkoglu, Cevriye
    Resorlu, Hatice
    Ataman, Sebnem
    Bal, Ajda
    Kucukakkas, Okan
    Yurdakul, Ozan Volkan
    Melikoglu, Meltem Alkan
    Aydin, Yildiray
    Ayhan, Fikriye Figen
    Bodur, Hatice
    Calis, Mustafa
    Capkin, Erhan
    Devrimsel, Gul
    Gok, Kevser
    Hizmetli, Sami
    Kamanli, Ayhan
    Keskin, Yasar
    Kocabas, Hilal
    Kutluk, Oznur
    Sen, Nesrin
    Sendur, Omer Faruk
    Tekeoglu, Ibrahim
    Tolu, Sena
    Toprak, Murat
    Tuncer, Tiraje
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [32] Etanercept in patients with psoriatic arthritis: Sustained improvement in skin and joint disease
    Goffe, BS
    Gottlieb, A
    Lebwohl, M
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P55 - P55
  • [33] The correlation of skin and joint response in patients with psoriatic arthritis treated with infliximab
    Krueger, GG
    Antoni, C
    Bala, M
    Yan, S
    Zhao, N
    Beutler, A
    Guzzo, C
    Kavanaugh, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 319 - +
  • [34] Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis
    Valor-Mendez, Larissa
    Kleyer, Arnd
    Schett, Georg
    Manger, Bernhard
    Sticherling, Michael
    RHEUMATOLOGY, 2021, 60 (09) : E312 - E313
  • [35] PREDICTING JOINT AND SKIN REMISSION AT 24 WEEKS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Dougados, Maxime
    Keystone, Edward
    Heckaman, Michele
    Mease, Philip
    RHEUMATOLOGY, 2012, 51 : 87 - 88
  • [36] Concurrent efficacy of adalimumab against skin and joint disease in psoriatic arthritis
    Ritchlin, Christopher
    Mease, Philip J.
    Sasso, Eric
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1819 - 1819
  • [37] CORRELATION BETWEEN SKIN AND JOINT INVOLVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: EXPERIENCE FROM A THIRD LEVEL HOSPITAL
    Sieiro Santos, C.
    Moriano, C.
    Alvarez Castro, C.
    Larco Rojas, X. E.
    Diez Alvarez, E.
    Perez Sandoval, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1321 - 1321
  • [38] Association between Skin and Joint Involvement in Patients with Psoriatic Arthritis Treated with Adalimumab: Analysis of Data from a German Non-Interventional Study
    Thaci, Diamant
    Behrens, Frank
    Greger, Gerd
    Burkhardt, Harald
    Gnann, Holger
    Schopf, Rudolf
    Wittig, Bianca Maria
    DERMATOLOGY, 2015, 230 (03) : 213 - 221
  • [39] Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices
    Lubrano, Ennio
    Scriffignano, Silvia
    Belen Azuaga, Ana
    Ramirez, Julio
    Canete, Juan D.
    Perrotta, Fabio Massimo
    RMD OPEN, 2020, 6 (01):
  • [40] Comparison Between Composite Activity Indices to Assess Clinical Response to Biological Therapy in Patients with Psoriatic Arthritis
    Benavent, Diego
    Plasencia, Chamaida
    Navarro-Compan, Victoria
    Peiteado, Diana
    Nuno, Laura
    Monjo, Irene
    Fernandez, Elisa
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2019, 71